125 related articles for article (PubMed ID: 8380937)
21. Intrinsic 5-lipoxygenase activity is required for neutrophil responsivity.
Guidot DM; Repine MJ; Westcott JY; Repine JE
Proc Natl Acad Sci U S A; 1994 Aug; 91(17):8156-9. PubMed ID: 8058773
[TBL] [Abstract][Full Text] [Related]
22. Membrane association of active 5-lipoxygenase in resting cells. Evidence for novel regulation of the enzyme in the rat alveolar macrophage.
Coffey M; Peters-Golden M; Fantone JC; Sporn PH
J Biol Chem; 1992 Jan; 267(1):570-6. PubMed ID: 1309754
[TBL] [Abstract][Full Text] [Related]
23. Calcium-dependent eicosanoid metabolism by concanavalin A-stimulated human monocytes in vitro. Synergism with phorbol ester indicates separate regulation of leukotriene B4 synthesis and release.
Hoffman T; Brando C; Lizzio EF; Lee YL; Hansen M; Tripathi AK; Taplits M; Puri J; Bonvini E; Abrahamsen TG
J Immunol; 1991 Jan; 146(2):692-700. PubMed ID: 1846160
[TBL] [Abstract][Full Text] [Related]
24. Reduced release of leukotrienes B4 and C4 from alveolar macrophages of rats with silicosis.
Mohr C; Davis GS; Graebner C; Amann S; Hemenway DR; Gemsa D
Am J Respir Cell Mol Biol; 1992 Nov; 7(5):542-7. PubMed ID: 1329867
[TBL] [Abstract][Full Text] [Related]
25. Leukotriene B4 production by the human alveolar macrophage: a potential mechanism for amplifying inflammation in the lung.
Martin TR; Altman LC; Albert RK; Henderson WR
Am Rev Respir Dis; 1984 Jan; 129(1):106-11. PubMed ID: 6322626
[TBL] [Abstract][Full Text] [Related]
26. MK-886, a leukotriene biosynthesis inhibitor, induces antiproliferative effects and apoptosis in HL-60 cells.
Dittmann KH; Mayer C; Rodemann HP; Petrides PE; Denzlinger C
Leuk Res; 1998 Jan; 22(1):49-53. PubMed ID: 9585079
[TBL] [Abstract][Full Text] [Related]
27. Regulation of macrophage-derived fibroblast growth factor release by arachidonate metabolites.
Phan SH; McGarry BM; Loeffler KM; Kunkel SL
J Leukoc Biol; 1987 Aug; 42(2):106-13. PubMed ID: 3036988
[TBL] [Abstract][Full Text] [Related]
28. Bradykinin stimulates alveolar macrophages to release neutrophil, monocyte, and eosinophil chemotactic activity.
Sato E; Koyama S; Nomura H; Kubo K; Sekiguchi M
J Immunol; 1996 Oct; 157(7):3122-9. PubMed ID: 8816423
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics and pharmacodynamics of multiple oral doses of MK-0591, a 5-lipoxygenase-activating protein inhibitor.
Depré M; Friedman B; Van Hecken A; de Lepeleire I; Tanaka W; Dallob A; Shingo S; Porras A; Lin C; de Schepper PJ
Clin Pharmacol Ther; 1994 Jul; 56(1):22-30. PubMed ID: 8033491
[TBL] [Abstract][Full Text] [Related]
30. Prostaglandins inhibit 5-lipoxygenase-activating protein expression and leukotriene B4 production from dendritic cells via an IL-10-dependent mechanism.
Harizi H; Juzan M; Moreau JF; Gualde N
J Immunol; 2003 Jan; 170(1):139-46. PubMed ID: 12496393
[TBL] [Abstract][Full Text] [Related]
31. Eicosapentaenoic acid modulates arachidonic acid metabolism in rat alveolar macrophages.
Kobayashi J; Yokoyama S; Kitamura S
Prostaglandins Leukot Essent Fatty Acids; 1995 Apr; 52(4):259-62. PubMed ID: 7784475
[TBL] [Abstract][Full Text] [Related]
32. Cyclic-AMP level and eicosanoid release from alveolar macrophages are differentially affected by high and low dose of platelet activating factor.
Beusenberg FD; Bonta IL; van Amsterdam JG
Biochem Pharmacol; 1994 Feb; 47(3):588-90. PubMed ID: 8117329
[TBL] [Abstract][Full Text] [Related]
33. Studies of the inhibitory activity of MK-0591 (3-[1-(4-chlorobenzyl)-3-(t-butylthio)-5-(quinolin-2-yl-methoxy)-indol- 2-yl]-2,2-dimethyl propanoic acid) on arachidonic acid metabolism in human phagocytes.
Ménard L; Laviolette M; Borgeat P
Can J Physiol Pharmacol; 1992 Jun; 70(6):808-13. PubMed ID: 1423024
[TBL] [Abstract][Full Text] [Related]
34. ETH615, a synthetic inhibitor of leukotriene biosynthesis and function, also inhibits the production of and biological responses towards interleukin-8.
Kristensen M; Jinquan T; Thomsen MK; Zachariae C; Paludan K; Ahnfelt-Rønne I; Matsushima K; Thestrup-Pedersen K; Larsen CG
Exp Dermatol; 1993 Aug; 2(4):165-70. PubMed ID: 8162335
[TBL] [Abstract][Full Text] [Related]
35. WY-50,295 tromethamine, a novel, orally active 5-lipoxygenase inhibitor: biochemical characterization and antiallergic activity.
Grimes D; Sturm RJ; Marinari LR; Carlson RP; Berkenkopf JW; Musser JH; Kreft AF; Weichman BM
Eur J Pharmacol; 1993 May; 236(2):217-28. PubMed ID: 8391458
[TBL] [Abstract][Full Text] [Related]
36. Biochemical activity, pharmacokinetics, and tolerability of MK-886, a leukotriene biosynthesis inhibitor, in humans.
Depre M; Friedman B; Tanaka W; Van Hecken A; Buntinx A; DeSchepper PJ
Clin Pharmacol Ther; 1993 May; 53(5):602-7. PubMed ID: 8387904
[TBL] [Abstract][Full Text] [Related]
37. Blockade of leukotriene production by a single oral dose of MK-0591 in active ulcerative colitis.
Hillingsø J; Kjeldsen J; Laursen LS; Lauritsen K; von Spreckelsen S; Depré M; Friedman BS; Malmström K; Shingo S; Bukhave K
Clin Pharmacol Ther; 1995 Mar; 57(3):335-41. PubMed ID: 7697951
[TBL] [Abstract][Full Text] [Related]
38. Effect of the antirheumatic agent Tenidap on CD3, CD4, and CD8 expression and interleukin-1 and leukotriene B4 secretion in human peripheral blood mononuclear cells.
Conti P; Reale M; Barbacane RC; Stuard S; Placido F
Biochem Cell Biol; 1994; 72(9-10):397-402. PubMed ID: 7605611
[TBL] [Abstract][Full Text] [Related]
39. Sulfite induces release of lipid mediators by alveolar macrophages.
Beck-Speier I; Dayal N; Denzlinger C; Haberl C; Maier KL
Z Naturforsch C J Biosci; 1998; 53(3-4):264-72. PubMed ID: 9618940
[TBL] [Abstract][Full Text] [Related]
40. Ketoconazole inhibits alveolar macrophage production of inflammatory mediators involved in acute lung injury (adult respiratory distress syndrome).
Williams JG; Maier RV
Surgery; 1992 Aug; 112(2):270-7. PubMed ID: 1322565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
